ISID Home
about ISID | membership | programs | publications | resources | 14th ICID | site map
 
ProMed Home
 
  Navigation
Home
Subscribe/Unsubscribe
Search Archives
Announcements
Recalls/Alerts
Calendar of Events
Maps of Outbreaks
Submit Info
FAQs
Who's Who
Awards
Citing ProMED-mail
Links
Donations
About ProMED-mail
 
Archive Number 20090925.3359
Published Date 25-SEP-2009
Subject PRO> Influenza pandemic (H1N1) 2009 (55): vaccine formulation
INFLUENZA PANDEMIC (H1N1) 2009 (55): VACCINE FORMULATION
***********************************************
A ProMED-mail post
<http://www.promedmail.org>
ProMED-mail is a program of the
International Society for Infectious Diseases
<http://www.isid.org>

In this update:
[1] Seasonal H1N1 vaccine dispensable?
[2] Seasonal H1N1 vaccine creates risk?

******
[1] Seasonal H1N1 vaccine dispensable?
Date: Wed 23 Sep 2009
Source: Winnipeg Free Press, Canadian Press report [edited]
<http://www.winnipegfreepress.com/life/health/WHO-experts-say-it_s-safe-to-drop-old-H1N1-strain-from-seasonal-flu-shots-60723677.html>


Influenza experts have urged vaccine manufacturers to drop one of the 
older strains of flu from the seasonal shot for next year's [2010] 
Southern Hemisphere winter, saying there are so few of those viruses 
around anymore they don't pose a significant public health threat. 
But that good news was tempered by the panel's assessment of what is 
happening with another family [serotype] of influenza A virus, the 
H3N2s. Their recommendation of a new H3N2 component for the flu shot 
suggests the Northern Hemisphere may be facing a vaccine mismatch, if 
H3N2 viruses circulate much this winter [2009-2010]. "The predominant 
H3N2 virus circulating at the moment is not that contained in the 
Northern Hemisphere vaccine," said Gregory Hartl, a spokesperson for 
the World Health Organization. The expert panel drew up the 
recommendations for the WHO, which in turn advises countries and 
vaccine manufacturers what should go in flu shots. No one knows how 
big a role H3N2 viruses will play in the comi!
ng Northern Hemisphere flu season. But experts fear a double whammy; 
a flu season started early in the fall with swine flu [pandemic 
(H1N1) 2009 virus infection] followed by a wave of illness triggered 
by H3N2 viruses. That would make for a long and nasty flu season. 
H3N2 viruses typically cause more severe disease than seasonal H1N1 
viruses. And they prey on the elderly, a group largely spared by 
swine flu.

The WHO's experts, drawn from a network of key influenza laboratories 
around the world, meet twice a year to make recommendations on which 
strains of viruses manufacturers should include in flu shots. Because 
it takes months to make and distribute flu vaccine, they meet well in 
advance of the flu season. The meeting for the following Southern 
Hemisphere winter takes place in September; the group will reconvene 
in February to select the strains for the flu shot for the 2010-11 
Northern Hemisphere winter. They pore over global virus circulation 
patterns and reports of how similar or distinct new strains are 
compared to those included in the most recent seasonal flu shots.

For the 2010 Southern Hemisphere winter, they recommended 
manufacturers make vaccine to protect against 3 viruses, the pandemic 
H1N1, a new H3N2 and an influenza B virus from a group of viruses 
known as the Victoria lineage. But the group did not make a 
recommendation on whether those 3 vaccines should be bundled into 
one, the way the current seasonal shots are formulated, or whether 
pandemic vaccine should remain separate and the seasonal shot should 
contain only 2 components going forward. The WHO had asked the group 
to leave that decision to another group, the Strategic Advisory Group 
of Experts. The SAGE, as it's called, is set to meet in late October 
2009.

Influenza experts have been keenly watching to see if the new H1N1 
virus will follow the pattern of previous pandemic viruses and 
replace existing influenza A viruses. The H1N1 virus that caused the 
1918 pandemic disappeared when H2N2 materialized in 1957, triggering 
the Asian flu pandemic. When H3N2 sparked the 1968 Hong Kong flu 
pandemic, H2N2 viruses stopped circulating. But the dynamics this 
time around are different. That's because since 1977, 2 influenza A 
virus [serotypes] have co-existed in humans. That year H1N1 viruses 
similar to those that had circulated before the 1957 pandemic 
reappeared; the belief is a lab accident in Russia led to the release 
of the viruses. They didn't cause a pandemic because there was so 
much immunity to H1N1 viruses in people over about age 30. But the 
viruses did manage to reseed [?] themselves and have shared the stage 
with H3N2 viruses ever since.

Experts have been predicting the new H1 virus would supplant the old 
one, a phenomenon that appears to be underway. But they are less 
optimistic the pandemic virus can wipe out H3N2 viruses as well. 
"Let's put it this way: If it's going to push out a strain, which I 
suspect that it will, (seasonal) H1N1 would be the 1st candidate," 
Dr. Walter Dowdle predicted recently. Dowdle, the retired former head 
of the influenza laboratory at the U.S. Centers for Disease Control, 
has questioned whether the new virus has enough "muscle" to out 
compete H3N2 viruses. If the experience of 1957 and 1968 can be used 
as a guide, the world should know relatively quickly whether the 
pandemic virus will replace the old influenza A viruses, he said. "It 
took place essentially immediately. ... By the time the season was 
over, it was very clear that there was no more of the previous virus 
around."

Losing at least one of the old A viruses would be a relief, experts 
say. Flu labs and vaccine manufacturers don't want to have to 
contemplate the consequences of having 3 influenza A plus influenza B 
viruses circulating at the same time. "Ideally in formulating the 
vaccine, you'd like to deal with no more than 3 (components)," Dowdle 
said. "You'd like to deal with no more than 2." "You would prefer not 
to deal with 4."

If the pandemic virus manages to get rid of H3N2 as well as the old 
H1N1, public health might actually come to think fondly of this 
pandemic virus. Life would become a lot simpler, said Dr. Nancy Cox, 
current head of the CDC's influenza division. "Our lives have been 
really complicated by having so many different components in the 
vaccine. If we could go back to a single A and a single B or even a 
single A and 2 Bs, that would simplify our lives a lot."

[Byline: Helen Branswell]

--
Communicated by:
ProMED-mail <promed@promedmail.org>

******
[2] Seasonal H1N1 creates risk?
Date: Wed 23 Sep 2009
Source: CBC News, cbcnews.ca [edited]
<http://www.cbc.ca/health/story/2009/09/23/flu-shots-h1n1-seasonal.html>


Preliminary research suggests the seasonal flu shot may put people at 
greater risk for getting swine flu [i.e. pandemic (H1N1) 2009 virus 
infection], CBC News has learned. "There is some evidence that has 
been floated. It hasn't been validated yet, it's very preliminary," 
cautioned Dr. Don Low, microbiologist-in-chief at Mount Sinai 
Hospital in Toronto. "This is obviously important data to help guide 
policy decisions. How can we best protect people against influenza?" 
It's important to validate the information to make sure it's not just 
a fluke and that the observation is confirmed elsewhere, such as in 
the Southern Hemisphere, which just completed its seasonal flu 
season, Low added.

Four Canadian studies involved about 2000 people, health officials 
told CBC News. Researchers found people who had received the seasonal 
flu vaccine in the past were more likely to get sick with the H1N1 
[i.e. pandemic (H1N1)] virus.

Researchers know that, theoretically, when people are exposed to 
bacteria or a virus, it can stimulate the immune system to create 
antibodies that facilitate the entry of another strain of the virus. 
Dengue fever is one example, Low said.

The latest finding raises questions about the order in which to get 
flu shots. Across Canada, public health authorities are debating the 
idea of shortening, delaying or scrapping their seasonal flu 
vaccination campaign in favour of mass inoculation against H1N1 
[pandemic (H1N1) 2009 virus]. The main reason is that H1N1 may be the 
dominant strain of influenza circulating when the fall flu season 
hits, meaning it could be a waste of time and resources to mount a 
seasonal flu vaccine campaign.

Health authorities in Quebec are considering canceling or postponing 
seasonal flu shots for some groups, such as healthy, younger adults. 
The Public Health Agency of Canada says it's up to provinces and 
territories to decide on when to roll out flu shots. "We don't know 
with this year's [2009-2010] flu shot how it interacts with the 
pandemic flu shot, so it's a worry," said Dr. Michael Gardam, 
director of infectious diseases prevention and control at the Ontario 
Agency for Health Protection and Promotion.

Seasonal flu could also appear after Christmas, said Dr. David 
Scheifele, director of the vaccine evaluation centre at B.C. [British 
Columbia] Children's Hospital in Vancouver.

--
Communicated by:
ProMED-mail Rapporteur Mary Marshall

[Notwithstanding the imminent onset of the Northern Hemisphere 
influenza season and the predicted 2nd phase of the 2009 H1N1 
pandemic, there still appears to be a lack of unanimity regarding the 
best strategy to adopt to deal with the situation. - Mod.CP]

[see also:
Influenza pandemic (H1N1) 2009 (54): vaccine availability 20090921.3325
Influenza pandemic (H1N1) 2009 (53): vaccine donation 20090919.3290
Influenza pandemic (H1N1) 2009 (52): WHO update 66 20090918.3272
Influenza pandemic (H1N1) 2009 (51): antibody deficiency 20090917.3261
Influenza pandemic (H1N1) 2009 (50): oseltamivir-resistance 20090917.3260
Influenza pandemic (H1N1) 2009 (40): global update 20090906.3138
Influenza pandemic (H1N1) 2009 (30): assumptions 20090813.2879
Influenza pandemic (H1N1) 2009 (20): Peru, 33 percent asymptomatic 
20090730.2668
Influenza pandemic (H1N1) 2009 (10): vaccine 20090720.2577
Influenza pandemic (H1N1) 2009 - Viet Nam: patient data 20090708.2450]
...................................................cp/msp/lm

*##########################################################*
************************************************************
ProMED-mail makes every effort to  verify  the reports  that
are  posted,  but  the  accuracy  and  completeness  of  the
information,   and  of  any  statements  or  opinions  based
thereon, are not guaranteed. The reader assumes all risks in
using information posted or archived by  ProMED-mail.   ISID
and  its  associated  service  providers  shall not be  held
responsible for errors or omissions or  held liable for  any
damages incurred as a result of use or reliance upon  posted
or archived material.
************************************************************
Become     a    ProMED-mail    Premium     Subscriber     at
<http://www.isid.org/ProMEDMail_Premium.shtml>
************************************************************
Visit ProMED-mail's web site at <http://www.promedmail.org>.
Send  all  items  for   posting  to:   promed@promedmail.org

(NOT to  an  individual moderator).  If you do not give your
full name and  affiliation, it  may  not  be  posted.   Send
commands  to  subscribe/unsubscribe,   get  archives,  help,
etc. to: majordomo@promedmail.org.    For assistance  from a
human  being  send  mail  to:   owner-promed@promedmail.org.

############################################################
############################################################

about ISID | membership | programs | publications | resources
14th ICID | site map | ISID home

©2001,2009 International Society for Infectious Diseases
All Rights Reserved.
Read our privacy guidelines.
Use of this web site and related services is governed by the Terms of Service.